Millipore has launched the Milliflex Quantum rapid microbial detection system, which enables drug and vaccine manufacturers to respond to microorganism contamination early in the production process.
Roland Heinrich, vice-president of process monitoring in Millipore's Bioprocess Division, said: 'The Milliflex Quantum system provides results faster than traditional testing methods.
'It is designed to significantly improve product quality management, helping customers to release product to the market sooner and avoid line shutdowns.
'The system is based on two widely adopted technologies - membrane filtration, performed with proven Milliflex membrane filtration devices, and fluorescent staining - to ensure consistent, reliable results.
'In addition, the validation process is streamlined because it involves only minimal changes to the compendial tests currently used,' he added.
The Milliflex Quantum system is suitable for testing raw material, in-process samples, final product and environmental samples.
As the system is non-destructive, it enables operators to grow microorganisms in order to identify them with standard identification technology.
The Milliflex Quantum system consists of a reader, a camera and fluorescent reagents used in combination with the Milliflex Plus pump, Milliflex filtration devices and media cassettes.
It is said to be compact and simple to learn for smooth integration into an existing laboratory setup.
Millipore offers a range of services to support the system's implementation, including installation and operational and performance qualification guidelines.
